GL1X · GenesisL1 explorer

MolNFT v1 · #182037 · protein

A biphenyl inhibitor of EIF4E targeting an internal binding site enables the design of cell-permeable protac-degraders

7MEU: “A biphenyl inhibitor of EIF4E targeting an internal binding site enables the design of cell-permeable…”. X-ray diffraction, 2 ligands (MGP, Z5D). MolNFT v1 #182037 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
7MEU
Type
protein
Length
368 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
P06730
Ligands
MGP, Z5D

Structure

x-ray diffraction · 1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B—protein184—P06730

Ligands and binding sites

  • MGP · 7-methyl-guanosine-5'-triphosphate · ligand · 2 copies · chains A, B
  • Z5D · (2E)-2-{2-[4-([1,1'-biphenyl]-4-yl)-1,3-thiazol-2-yl]hydrazinylidene}-3-(2-nitrophenyl)propanoic acid · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 7MEU · A biphenyl inhibitor of eIF4E targeting an internal binding site enables the design of… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.